Bone marrow-derived mesenchymal stem cells combined with intramuscular injection promote the healing of diabetic foot ulcers: a systematic review and meta-analysis
Zhang X., Liu G., You Y., Lu H., Fan W., Li W.
Meta-analysis with a reported sample of 2059 on Diabetic Foot, Chronic Wound, published in Front Endocrinol (Lausanne) (2026) — summary generated from the PubMed abstract.
Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Meta-analysis
- Journal
- Front Endocrinol (Lausanne) (2026)
- Reported sample size
- 2059
- Source database
- Europe PMC
- PMID
- 41884216
- PMCID
- PMC13008641
- DOI
- 10.3389/fendo.2026.1763071
Abstract (original English)
Background Diabetic foot ulcers (DFUs) represent a debilitating complication of diabetes characterized by high rates of morbidity and mortality, yet conventional management often yields limited efficacy. Although cell-based therapies offer a promising therapeutic avenue, their clinical efficacy and optimal target populations remain to be definitively established. Methods We searched databases including PubMed, Embase, the Cochrane Library, Web of Science, and the China National Knowledge Infrastructure from inception to November 2025 for randomized controlled trials (RCTs). Study quality was assessed using the Revised Cochrane risk-of-bias tool for randomized trials. Meta-analysis, subgroup analysis, and heterogeneity analysis were performed using R software (version 4.3.3). Sensitivity analysis was conducted via the leave-one-out method. Results Thirty-two RCTs involving 2059 patients were included, assessing nine core outcomes including ulcer healing rate and amputation rate. Pooled analysis demonstrated that cell therapy significantly improved the ulcer healing rate (OR = 4.64, 95% CI: 3.11 to 6.90), reduced the amputation rate (OR = 0.29, 95% CI: 0.18 to 0.49), enhanced limb perfusion (ABI MD = 0.14, 95% CI: 0.05 to 0.22; TcPO 2 MD = 11.58, 95% CI: 5.36 to 17.80), alleviated pain (resting pain score MD = -1.04, 95% CI: -1.49 to -0.59), reduced ulcer area (MD = -2.15, 95% CI
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level AMeta-analysisPubMed
Efficacy of Stem Cell-Derived Exosomes in Promoting Diabetic Foot Ulcer Healing: A Meta-Analysis of Preclinical Animal Studies.
Meta-analysis on Diabetic Foot, Chronic Wound, published in J Diabetes Res (2026) — summary generated from the PubMed abstract.
- 2026
J Diabetes Res - Level AMeta-analysisEurope PMC
Comparative efficacy of advanced therapeutic modalities for diabetic foot ulcers: a systematic review and meta-analysis including NPWT, stem cells, ESWT, and bioengineered treatments
Meta-analysis on Diabetic Foot, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.
- 2026
Front Bioeng Biotechnol - Level AMeta-analysisPubMed
Therapeutic potential of adipose-derived stem cells for diabetic foot ulcers: a systematic review and meta-analysis.
Meta-analysis on Diabetic Foot, Chronic Wound, published in Diabetol Metab Syndr (2025) — summary generated from the PubMed abstract.
- 2025
Diabetol Metab Syndr6 citations - Level AMeta-analysisPubMed
A meta-analysis on application and prospect of cell therapy in the treatment of diabetes mellitus.
Meta-analysis on Diabetic Foot, Autoimmune Research, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther - Level AMeta-analysisEurope PMC
Comparison of the efficacy of 12 interventions in the treatment of diabetic foot ulcers: a network meta-analysis
Meta-analysis with a reported sample of 356 on Diabetic Foot, Chronic Wound, published in PeerJ (2025) — summary generated from the PubMed abstract.
- 2025
- n = 356
PeerJ1 citations - Level ASystematic ReviewEurope PMC
A Systematic Review of Submetatarsal Fat Pad Augmentation for the Treatment and Prevention of Diabetes-Related Foot Ulceration
Systematic Review with a reported sample of 76 on Diabetic Foot, Chronic Wound, published in J Foot Ankle Res (2025) — summary generated from the PubMed abstract.
- 2025
- n = 76
J Foot Ankle Res1 citations